IL99031A - Solid oral pharmaceutical preparations containing epiphamide - Google Patents

Solid oral pharmaceutical preparations containing epiphamide

Info

Publication number
IL99031A
IL99031A IL9903191A IL9903191A IL99031A IL 99031 A IL99031 A IL 99031A IL 9903191 A IL9903191 A IL 9903191A IL 9903191 A IL9903191 A IL 9903191A IL 99031 A IL99031 A IL 99031A
Authority
IL
Israel
Prior art keywords
weight
ifosfamide
parts
capsules
flow regulating
Prior art date
Application number
IL9903191A
Other languages
English (en)
Hebrew (he)
Other versions
IL99031A0 (en
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of IL99031A0 publication Critical patent/IL99031A0/xx
Publication of IL99031A publication Critical patent/IL99031A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891Coated capsules; Multilayered drug free capsule shells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL9903191A 1990-08-03 1991-08-01 Solid oral pharmaceutical preparations containing epiphamide IL99031A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4024683 1990-08-03
SG181694A SG181694G (en) 1990-08-03 1994-12-30 Solid oral administration forms containing ifosfamide as active agent

Publications (2)

Publication Number Publication Date
IL99031A0 IL99031A0 (en) 1992-07-15
IL99031A true IL99031A (en) 1996-09-04

Family

ID=25895607

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9903191A IL99031A (en) 1990-08-03 1991-08-01 Solid oral pharmaceutical preparations containing epiphamide

Country Status (33)

Country Link
US (1) US5158776A (no)
EP (1) EP0469440B1 (no)
JP (2) JP3061898B2 (no)
KR (1) KR0177170B1 (no)
CN (1) CN1046851C (no)
AR (1) AR247484A1 (no)
AT (1) ATE110261T1 (no)
AU (2) AU643309B2 (no)
BG (1) BG60900B1 (no)
CA (1) CA2048367C (no)
CZ (1) CZ280475B6 (no)
DE (2) DE4124481A1 (no)
DK (1) DK0469440T3 (no)
EG (1) EG19690A (no)
ES (1) ES2058999T3 (no)
FI (1) FI97951C (no)
HK (1) HK15695A (no)
HR (1) HRP920575B1 (no)
HU (1) HU206268B (no)
IE (1) IE66378B1 (no)
IL (1) IL99031A (no)
LT (1) LT3528B (no)
LV (1) LV10043B (no)
MC (1) MC2274A1 (no)
MX (1) MX9100441A (no)
NO (1) NO178252C (no)
NZ (1) NZ239222A (no)
PT (1) PT98532B (no)
RO (1) RO113611B1 (no)
SG (1) SG181694G (no)
SI (1) SI9111342B (no)
SK (2) SK279740B6 (no)
ZA (1) ZA916124B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0804174A4 (en) * 1993-07-21 1998-09-09 Univ Kentucky Res Found MULTI-CHAMBER HARD CAPSULES WITH CONTROLLED DELIVERY CHARACTERISTICS
ITFI970184A1 (it) * 1997-07-30 1999-01-30 Menarini Farma Ind Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico
DE19733305A1 (de) * 1997-08-01 1999-02-04 Asta Medica Ag Pharmazeutische Zusammensetzung enthaltend Ifosfamid und Carnitin
US6103297A (en) * 1998-01-14 2000-08-15 Matsushita Electronics Corporation Method of manufacturing cathode-ray tube
DE19826517B4 (de) * 1998-06-15 2006-03-23 Baxter Healthcare S.A. Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette
US20040253307A1 (en) * 2003-02-04 2004-12-16 Brian Hague Sugar-free oral transmucosal solid dosage forms and uses thereof
DE102005008797A1 (de) * 2005-02-25 2006-09-07 Baxter International Inc., Deerfield Trofosfamid-haltige Filmtabletten und Verfahren zu deren Herstellung
CN106413706A (zh) 2014-01-06 2017-02-15 铁治疗控股公司 三麦芽酚铁的剂量方案
GB201418710D0 (en) 2014-10-21 2014-12-03 Iron Therapeutics Holdings Ag Dosage regimen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5646807A (en) * 1979-09-27 1981-04-28 Japan Atom Energy Res Inst Production of composition of complex gradually releasing physiologically active substance
DE3111428A1 (de) * 1981-03-24 1982-10-07 Asta-Werke Ag, Chemische Fabrik, 4800 Bielefeld Oxazaphosphorin-4-thio-alkansulfonsaeuren und deren neutrale salze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
US4618692A (en) * 1981-09-03 1986-10-21 Asta-Werke Aktiengesellschaft 4-carbamoyloxy-oxazaphosphorins
US5019385A (en) * 1984-11-09 1991-05-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Novel lymphopine LK 2 and pharmaceutic compositions containing same
DE3722043A1 (de) * 1986-07-11 1988-01-14 Asta Werke Ag Chem Fab Loesungen von oxazaphosphorinen mit verbesserter stabilitaet und verfahren zu deren herstellung
DE3804686A1 (de) * 1988-02-15 1989-08-24 Henkel Kgaa Arzneimittel mit einer kombination von cytostatika bzw. hormontherapeutika und phosphonoderivaten

Also Published As

Publication number Publication date
CZ280475B6 (cs) 1996-01-17
SK279740B6 (sk) 1999-03-12
AR247484A1 (es) 1995-01-31
JP3545300B2 (ja) 2004-07-21
IE912774A1 (en) 1992-02-12
SK279739B6 (sk) 1999-03-12
CS240991A3 (en) 1992-03-18
AU8158991A (en) 1992-02-06
HK15695A (en) 1995-02-10
MC2274A1 (fr) 1993-06-23
NO178252B (no) 1995-11-13
IE66378B1 (en) 1995-12-27
ATE110261T1 (de) 1994-09-15
MX9100441A (es) 1992-04-01
HU912594D0 (en) 1992-01-28
LV10043B (en) 1995-06-20
JPH04243828A (ja) 1992-08-31
NO178252C (no) 1996-02-21
PT98532B (pt) 1999-01-29
DE4124481A1 (de) 1992-02-06
AU4483693A (en) 1993-11-11
LV10043A (lv) 1994-05-10
AU649184B2 (en) 1994-05-12
KR0177170B1 (ko) 1999-03-20
NO913019L (no) 1992-02-04
HRP920575A2 (en) 1995-04-30
DE59102620D1 (de) 1994-09-29
PT98532A (pt) 1992-06-30
HU206268B (en) 1992-10-28
IL99031A0 (en) 1992-07-15
SI9111342B (sl) 1998-10-31
CN1058715A (zh) 1992-02-19
AU643309B2 (en) 1993-11-11
DK0469440T3 (da) 1994-11-14
KR920003963A (ko) 1992-03-27
CN1046851C (zh) 1999-12-01
LT3528B (en) 1995-11-27
FI913710A (fi) 1992-02-04
FI913710A0 (fi) 1991-08-02
US5158776A (en) 1992-10-27
CA2048367C (en) 2000-05-23
ES2058999T3 (es) 1994-11-01
HUT59316A (en) 1992-05-28
EG19690A (en) 1995-09-30
ZA916124B (en) 1992-04-29
CA2048367A1 (en) 1992-02-04
NO913019D0 (no) 1991-08-02
SG181694G (en) 1995-05-12
RO113611B1 (ro) 1998-09-30
LTIP921A (en) 1995-03-27
EP0469440A1 (de) 1992-02-05
FI97951C (fi) 1997-03-25
EP0469440B1 (de) 1994-08-24
NZ239222A (en) 1993-01-27
HRP920575B1 (en) 1999-04-30
BG60900B1 (bg) 1996-06-28
FI97951B (fi) 1996-12-13
JP2000229860A (ja) 2000-08-22
JP3061898B2 (ja) 2000-07-10
SI9111342A (sl) 1998-04-30

Similar Documents

Publication Publication Date Title
FI113336B (fi) Menetelmä tramadolisuolaa sisältävän lääkeaineen valmistamiseksi, jolla on viivästynyt vaikuttavan aineen vapautuminen
US5273758A (en) Directly compressible polyethylene oxide vehicle for preparing therapeutic dosage forms
EP0317878B1 (de) Stabilisierte Arzneistoffe, Verfahren zu ihrer Herstellung sowie stabile Arzneizubereitungen
DE60224194T3 (de) Arzneizusammensetzungen enthaltend terbinafin und deren verwendung
US4155993A (en) Prolonged-release pharmaceutical compositions for oral administration, their methods of making and use
HUE031251T2 (en) Controlled release oral dosage form containing oxycodone
CA2048367C (en) Solid oral forms of application containing ifosfamide as active substance
US20020143058A1 (en) Process for preparing non-hygroscopic sodium valproate composition
KR100315618B1 (ko) 베타-페닐프로피오페논유도체의지연방출성미세정제
JP3884056B1 (ja) 口腔内速崩錠の製造方法
JPH1192369A (ja) 医薬品調製物、その製造方法及びシランセトロンの安定化のための酸性添加剤の使用
US20070160667A1 (en) Controlled release formulation of divalproex sodium
KR20200110396A (ko) 갑상샘 호르몬 또는 이의 유사체를 제공하는 조성물 및 방법
JP3967767B1 (ja) 口腔内速崩錠の製造方法
EP1815850A1 (en) Controlled release formulation of divalproic acid and its derivatives
KR20190142464A (ko) 콜린 알포세레이트 함유 약제학적 조성물
JPH11513046A (ja) カプトプリル錠剤
CN112449601B (zh) 含纳呋拉啡口腔崩解片
JP4696210B2 (ja) イソソルビド‐5‐モノニトレートを有効成分とする徐放性錠剤及びその製造方法
WO2007081341A1 (en) Controlled release formulation of divalproic acid and its derivatives
SK11072000A3 (sk) Tiagabínové prostriedky s predĺženým uvoľňovaním so zníženými vedľajšími účinkami
HUE029193T2 (en) Delayed release drug formulations of thiocolchicoside
KR20050085386A (ko) 불안증 치료 방법 및 조성물
HU215191B (hu) Eljárás Levodopa és Carbidopa hatóanyag-kombinációt tartalmazó, szabályozott hatóanyag-leadású, központi dopaminhiányos állapotok kezeléséhez alkalmas orális gyógyszerkészítmény előállítására
MXPA00012079A (en) Cyclophosphamide coated tablets

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
RH Patent void
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired